Developmental outcomes in persistent pulmonary hypertension treated with nitric oxide therapy
- 1 February 2009
- journal article
- Published by Wiley in Pediatrics International
- Vol. 51 (1) , 79-83
Abstract
The aim of the present study was to assess 3 year auditory and neurodevelopmental outcomes of persistent pulmonary hypertension of the newborn (PPHN) before and after introducing inhaled nitric oxide (i-NO) therapy, and to detect the clinical factors affecting poor outcome. A retrospective historical cohort study of 26 survivors with PPHN with oxygenation index (OI) >or=25 (13 infants without i-NO therapy, control group; 13 with i-NO therapy, i-NO group) was performed. Auditory brainstem response (ABR) at 6 and 12 months and neurodevelopmental outcomes at 3 years of age were evaluated. ABR abnormalities at 6 months were observed in one infant in the i-NO group and six in the control group (P = 0.04). At 1 year, one infant in the i-NO group and two of six infants in the control group still had ABR abnormality. In the i-NO group, two children had abnormal neurodevelopmental outcomes, as compared with five children in the control group at 3 year follow up. Two children in the control group and no children in the i-NO group had hearing loss at 3 years of age. Hypocapnea (P = 0.04) and elevated creatine phosphokinase (P = 0.04) were found to be most predictive for neurodevelopmental abnormality. Avoidance of excessive hypocapnea via introduction of i-NO therapy might reduce both ABR and neurodevelopmental abnormalities.Keywords
This publication has 23 references indexed in Scilit:
- Ototoxic drugs and sensorineural hearing loss following severe neonatal respiratory failureActa Paediatrica, 2006
- Neurodevelopmental Outcomes of Premature Infants Treated with Inhaled Nitric OxideNew England Journal of Medicine, 2005
- Factors Associated With Sensorineural Hearing Loss Among Survivors of Extracorporeal Membrane Oxygenation TherapyPediatrics, 2005
- Inhaled Nitric Oxide and Gentle Ventilation in the Treatment of Pulmonary Hypertension of the Newborn — a Single-Center, 5-Year ExperienceJournal of Perinatology, 2002
- Child Health Status, Neurodevelopmental Outcome, and Parental Satisfaction in a Randomized, Controlled Trial of Nitric Oxide for Persistent Pulmonary Hypertension of the NewbornPediatrics, 2001
- Inhaled nitric oxide in term and near-term infants: Neurodevelopmental follow-up of The Neonatal Inhaled Nitric Oxide Study Group (NINOS)The Journal of Pediatrics, 2000
- Low-Dose Nitric Oxide Therapy for Persistent Pulmonary Hypertension of the NewbornNew England Journal of Medicine, 2000
- Inhaled Nitric Oxide and Persistent Pulmonary Hypertension of the NewbornNew England Journal of Medicine, 1997
- Inhaled Nitric Oxide in Full-Term and Nearly Full-Term Infants with Hypoxic Respiratory FailureNew England Journal of Medicine, 1997
- Persistent Fetal CirculationAmerican Journal of Diseases of Children, 1985